
Further expansion for Nonwovenn
New developments include a translucent nonwoven allowing for visual inspection of incision sites without removing a dressing.
26th June 2025
Innovation in Textiles
|
Bridgwater, United Kingdom
Nonwovenn has announced a significant investment in a new medical manufacturing suite at its HQ in Bridgwater, UK.
This strategic investment marks a major milestone in Nonwovenn’s three-year growth plan, which aims to deliver 14% year-on-year growth from its MediTech division, through the innovation pipeline, strategic partnerships and expansion.
The newly-commissioned medical manufacturing facility features controlled environments that are purpose-built for precision manufacturing and includes a ‘Class 8’ standard performing cleanroom which is designed to meet even the most stringent medical industry standards.
This development was supported by a joint investment from a key customer in the sector and underlines the strength of Nonwovenn’s collaborative approach to partnerships and the overall trust that is placed in the long-term vision of the business.
The research and development team has also delivered several high-impact innovations launched over the last year. These include x-ray detectable materials to enhance safety and traceability in surgical applications and reinforced CMC hydrofibre for improved durability and absorption in wound care.
The team has also developed a translucent nonwoven solution for use as a surgical site dressing scaffold to allow for visual inspection of incision sites without the need to remove the dressing.
All three innovations come as a direct result of research and development programmes to support client needs.
Nonwovenn has also strengthened its team with the appointment of Ross Ward as business director of carbon. Ward is a leading expert in carbon technologies and his expertise is already accelerating innovation in areas such as ostomy care and odour control.
“Our growth in the MediTech sector is not just about the facilities or the product, it’s about the lasting improvements it can make to patient care and outcomes,” said Nonwovenn’s commercial director Silke Brand. “We are really working to shape the future of medical textiles and this investment will help us achieve that.”
Business intelligence for the fibre, textiles and apparel industries: technologies, innovations, markets, investments, trade policy, sourcing, strategy...
Find out more